We are live on ! Find out more
AXNX

Axonics, Inc. Common Stock

Delisted

AXNX was delisted on the 14th of November, 2024.

235 hedge funds and large institutions have $3.26B invested in Axonics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 82 funds opening new positions, 41 increasing their positions, 87 reducing their positions, and 74 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more funds holding in top 10

Funds holding in top 10: 418 (+14)

11% more first-time investments, than exits

New positions opened: 82 | Existing positions closed: 74

2% more funds holding

Funds holding: 230235 (+5)

2% more capital invested

Capital invested by funds: $3.19B → $3.26B (+$73M)

20% less call options, than puts

Call options by funds: $17.3M | Put options by funds: $21.6M

53% less repeat investments, than reductions

Existing positions increased: 41 | Existing positions reduced: 87

Holders
235
Holders Change
+5
Holders Change %
+2.17%
% of All Funds
3.39%
Holding in Top 10
18
Holding in Top 10 Change
+14
Holding in Top 10 Change %
+350%
% of All Funds
0.26%
New
82
Increased
41
Reduced
87
Closed
74
Calls
$17.3M
Puts
$21.6M
Net Calls
-$4.25M
Net Calls Change
-$9.34M
Name Holding Trade Value Shares
Change
Change in
Stake
Amundi
26
Amundi
France
$42.9M -$3.03M -44,960 -7%
Qube Research & Technologies (QRT)
27
Qube Research & Technologies (QRT)
United Kingdom
$39.4M +$38.1M +564,241 +8,055%
MAM
28
Melqart Asset Management
United Kingdom
$35.4M +$34.6M +512,759 New
Northern Trust
29
Northern Trust
Illinois
$32.7M -$11.3M -167,045 -26%
N
30
Nuveen
North Carolina
$31.4M -$9.33M -138,217 -23%
Fidelity Investments
31
Fidelity Investments
Massachusetts
$30M -$337M -4,990,515 -92%
DKCM
32
Davidson Kempner Capital Management
New York
$29.4M +$28.8M +426,806 New
Charles Schwab
33
Charles Schwab
California
$27.6M -$174K -2,576 -0.6%
Goldman Sachs
34
Goldman Sachs
New York
$27M -$15.5M -229,419 -37%
KI
35
Kapitalo Investimentos
Brazil
$24.4M +$23.8M +353,181 New
UBS Group
36
UBS Group
Switzerland
$23.4M +$19M +281,143 +489%
Morgan Stanley
37
Morgan Stanley
New York
$21.8M -$17.4M -258,361 -45%
SFM
38
Soros Fund Management
New York
$20.4M +$20M +295,955 New
PSAMP
39
P. Schoenfeld Asset Management (PSAM)
New York
$17.9M +$17.5M +259,075 New
HSBC Holdings
40
HSBC Holdings
United Kingdom
$17.6M +$12.8M +189,756 +290%
Impax Asset Management Group
41
Impax Asset Management Group
United Kingdom
$16.9M
TMAM
42
Tokio Marine Asset Management
Japan
$16.6M +$16.2M +240,300 New
FCM
43
Farallon Capital Management
California
$15.5M +$15.2M +225,000 New
PMAM
44
Picton Mahoney Asset Management
Ontario, Canada
$13.8M +$13.5M +200,000 New
Renaissance Technologies
45
Renaissance Technologies
New York
$13.5M +$7.17M +106,300 +119%
Bank of New York Mellon
46
Bank of New York Mellon
New York
$13.4M -$1.59M -23,505 -11%
Janus Henderson Group
47
Janus Henderson Group
United Kingdom
$12.3M +$10.4M +154,149 +638%
GF
48
Gabelli Funds
New York
$12.3M +$12M +177,925 New
SCM
49
Segantii Capital Management
Hong Kong
$11.4M +$11.1M +165,000 New
OAM
50
Oberweis Asset Management
Illinois
$11.3M -$1.01M -14,900 -8%

AXNX Hedge Fund Activity: Q1 2024 in Review

235 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Axonics, Inc. Common Stock (AXNX) for Q1 2024, worth a combined $3.26B — up 2.3% from $3.19B a quarter earlier.

Buyers outnumbered sellers: 82 funds opened new AXNX positions and 74 closed out — a net gain of 8 holders — while 41 added to existing stakes and 87 trimmed.

The largest buyer was UBS O'Connor, adding an estimated $128M. The largest seller was Fidelity Investments, cutting an estimated $337M.

  • 235 institutional investors held Axonics, Inc. Common Stock (AXNX) as of Q1 2024, up from 230 in Q4 2023.
  • Funds reported $3.26B of Axonics, Inc. Common Stock stock for Q1 2024, up 2.3% quarter-over-quarter.
  • 82 funds opened new Axonics, Inc. Common Stock positions in Q1 2024 and 74 closed out, a net change of +8 holders.
  • The largest Axonics, Inc. Common Stock buyer in Q1 2024 was UBS O'Connor, an estimated $128M added.
  • The largest Axonics, Inc. Common Stock seller in Q1 2024 was Fidelity Investments, an estimated $337M sold.

Based on aggregated 13F filings for Q1 2024.